Leading-edge medical care through clinical research.
Getting care at AdventHealth Tampa, formerly Florida Hospital Tampa, means getting access to the latest heart care research studies, procedures, and technologies including access to heart treatment clinical trials that aren’t widely available elsewhere.
Active Research Trials
AKI: The purpose of this study is to evaluate the efficacy of post-surgery treatment with ASP1128 in subjects at risk for acute kidney injury (AKI) following CABG and/or valve surgery Lead: Mari Hardy
BIOFLOW-VII: Confirming that the clinical performance of the Orsiro stent in a real-world setting is similar to the clinical performance observed for Orsiro in the BIOFLOW-V Investigational Device Exemption pivotal trial. Lead: Juliet Bala
CADFEM: Phase signal acquisition system (PSAQ), a medical device system. Lead: Mari Hardy
FROZEN: To establish the safety and effectiveness of the Boston Scientific Cardiac Cryoablation System for treatment of symptomatic, drug refractory, recurrent, paroxysmal atrial fibrillation. Lead: Cynthia Paysor
EP0092: To evaluate the efficacy, safety and tolerability of the 3 selected dose regimens of padsevonil (PSL) administered concomitantly with up to 3 anti-epileptic drugs (AEDs) compared with placebo for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy. Lead: Poliana Desarden
DIGESTIVE HEALTH TRIALS
ABBVIE M14-234:A Study to Evaluate the Safety and Efficacy of Upadacitinib for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis.
ABBVIE M14-431: A Study of the Efficacy and Safety of Upadacitinib in Subjects with Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy.
ABBVIE M14-433: A Study of the Efficacy and Safety of Upadacitinib in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies. Lead: Christopher Carr
ABBVIE M14-533: A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib in Subjects With Ulcerative Colitis.
PANOVA-3: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant with Gemcitabine and Nab-paclitaxel. Lead: Trenton Lippert
AMG-570/SLE: Determine if AMG 570 could be a useful therapeutic agent in the current treatment landscape where subjects with systemic lupus erythematosus (SLE) have ongoing disease activity despite treatment with standard of care therapies. Lead: Courtney Humiston
B7931028: Assessment of PF-06700841 in participants with moderate to severe active, generalized Systemic Lupus Erythematosus (SLE) that have inadequate response to standard of care. Lead: Dianne Morales
BMS-IM1121/SLE: An Investigational Study to Evaluate BMS-986165 in Patients with Systemic Lupus Erythematosus.
GSK-20190: Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate. Lead: Judy Lara
GSK-20218: Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors. Lead: Judy Lara
PA0010: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE OPTIMAL).